Amikacin binds to the 30s subunit of the bacterial ribosome, preventing the read of the RNA, thus prevents the synthesis of necessary proteins for its growth and development.CAS number is 39831-55-5, and the molecular formula is c22h43n5o13.2 (H2SO4).

Market Analysis and Insights: Global Amikacin Sulfate Market
The global Amikacin Sulfate market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027.

Global Amikacin Sulfate Scope and Market Size
The global Amikacin Sulfate market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Amikacin Sulfate market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type
Purity≥98%
Purity≥99%

Segment by Application
Amikacin Sulfate Injection
Other

The Amikacin Sulfate market is analysed and market size information is provided by regions (countries). Segment by Application, the Amikacin Sulfate market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company
Chengdu Brilliant Pharmaceutical Group
Chongqing Daxin Pharmaceutical
Interquim Mexico
CONBA Group
Suanfarma
HangZhou HuiSheng Biotech Pharmaceutical
Iffect Chemphar
Triveni Interchem
NC Pharm
Qilu Pharmaceutical